In vivo Metabolic Profiles as Determined by 31P and short TE 1H MR-Spectroscopy : No Difference Between Patients with IDH Wildtype and IDH Mutant Gliomas.
Katharina J WengerElke HattingenKea FranzJoachim SteinbachOliver BährUlrich PilatusPublished in: Clinical neuroradiology (2017)
Using 3D-CSI data acquisition, in vivo 31P MR spectroscopic measurement of phospholipid metabolites could not distinguish between IDHmut and IDHwt.